APOLLO MEDICAL HOLDINGS INC (AMEH) Stock Fundamental Analysis

NASDAQ:AMEH • US03763A2078

40.82 USD
-0.88 (-2.11%)
At close: Feb 23, 2024
40.82 USD
0 (0%)
After Hours: 2/23/2024, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

AMEH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. AMEH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. AMEH shows excellent growth, but is valued quite expensive already. These ratings would make AMEH suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year AMEH was profitable.
  • AMEH had a positive operating cash flow in the past year.
AMEH Yearly Net Income VS EBIT VS OCF VS FCFAMEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.27%, AMEH is in the better half of the industry, outperforming 74.58% of the companies in the same industry.
  • The Return On Equity of AMEH (7.71%) is better than 71.19% of its industry peers.
  • AMEH's Return On Invested Capital of 7.06% is fine compared to the rest of the industry. AMEH outperforms 75.42% of its industry peers.
  • AMEH had an Average Return On Invested Capital over the past 3 years of 7.61%. This is in line with the industry average of 8.98%.
Industry RankSector Rank
ROA 4.27%
ROE 7.71%
ROIC 7.06%
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
AMEH Yearly ROA, ROE, ROICAMEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 500 1K 1.5K 2K

1.3 Margins

  • The Profit Margin of AMEH (3.45%) is better than 75.42% of its industry peers.
  • In the last couple of years the Profit Margin of AMEH has grown nicely.
  • With a decent Operating Margin value of 7.61%, AMEH is doing good in the industry, outperforming 77.97% of the companies in the same industry.
  • AMEH's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 16.34%, AMEH is not doing good in the industry: 70.34% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of AMEH has grown nicely.
Industry RankSector Rank
OM 7.61%
PM (TTM) 3.45%
GM 16.34%
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
AMEH Yearly Profit, Operating, Gross MarginsAMEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 -20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMEH is destroying value.
  • AMEH has more shares outstanding than it did 1 year ago.
  • AMEH has a better debt/assets ratio than last year.
AMEH Yearly Shares OutstandingAMEH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
AMEH Yearly Total Debt VS Total AssetsAMEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 4.53 indicates that AMEH is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of AMEH (4.53) is better than 83.90% of its industry peers.
  • The Debt to FCF ratio of AMEH is 1.89, which is an excellent value as it means it would take AMEH, only 1.89 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of AMEH (1.89) is better than 85.59% of its industry peers.
  • AMEH has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of AMEH (0.35) is better than 65.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.89
Altman-Z 4.53
ROIC/WACC0.85
WACC8.27%
AMEH Yearly LT Debt VS Equity VS FCFAMEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.35, AMEH is in the better half of the industry, outperforming 79.66% of the companies in the same industry.
  • AMEH has a Quick Ratio of 2.35. This indicates that AMEH is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of AMEH (2.35) is better than 81.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
AMEH Yearly Current Assets VS Current LiabilitesAMEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The earnings per share for AMEH have decreased strongly by -29.58% in the last year.
  • The Earnings Per Share has been growing by 42.03% on average over the past years. This is a very strong growth
  • Looking at the last year, AMEH shows a very strong growth in Revenue. The Revenue has grown by 27.05%.
  • Measured over the past years, AMEH shows a very strong growth in Revenue. The Revenue has been growing by 81.94% on average per year.
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%

3.2 Future

  • AMEH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.59% yearly.
  • AMEH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.59% yearly.
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AMEH Yearly Revenue VS EstimatesAMEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
AMEH Yearly EPS VS EstimatesAMEH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • AMEH is valuated quite expensively with a Price/Earnings ratio of 40.82.
  • Based on the Price/Earnings ratio, AMEH is valued a bit cheaper than 60.17% of the companies in the same industry.
  • AMEH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.19.
  • AMEH is valuated quite expensively with a Price/Forward Earnings ratio of 28.34.
  • Based on the Price/Forward Earnings ratio, AMEH is valued a bit cheaper than 62.71% of the companies in the same industry.
  • AMEH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 40.82
Fwd PE 28.34
AMEH Price Earnings VS Forward Price EarningsAMEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMEH indicates a somewhat cheap valuation: AMEH is cheaper than 61.86% of the companies listed in the same industry.
  • 73.73% of the companies in the same industry are more expensive than AMEH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.06
EV/EBITDA 15.55
AMEH Per share dataAMEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMEH does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as AMEH's earnings are expected to grow with 15.59% in the coming years.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AMEH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

APOLLO MEDICAL HOLDINGS INC

NASDAQ:AMEH (2/23/2024, 8:00:00 PM)

After market: 40.82 0 (0%)

40.82

-0.88 (-2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners53.14%
Inst Owner Change0.58%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Revenue(TTM)1.33B
Net Income(TTM)45.80M
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE 40.82
Fwd PE 28.34
P/S 1.43
P/FCF 17.06
P/OCF 14.21
P/B 3.2
P/tB 7.79
EV/EBITDA 15.55
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 7.71%
ROCE 11.61%
ROIC 7.06%
ROICexc 10.35%
ROICexgc 25.21%
OM 7.61%
PM (TTM) 3.45%
GM 16.34%
FCFM 8.4%
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexgc growth 3Y1.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.89
Debt/EBITDA 1.76
Cap/Depr 132.23%
Cap/Sales 1.68%
Interest Coverage 8.45
Cash Conversion 113.54%
Profit Quality 243.47%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 4.53
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A

APOLLO MEDICAL HOLDINGS INC / AMEH FAQ

Can you provide the ChartMill fundamental rating for APOLLO MEDICAL HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to AMEH.


What is the valuation status of APOLLO MEDICAL HOLDINGS INC (AMEH) stock?

ChartMill assigns a valuation rating of 3 / 10 to APOLLO MEDICAL HOLDINGS INC (AMEH). This can be considered as Overvalued.


What is the profitability of AMEH stock?

APOLLO MEDICAL HOLDINGS INC (AMEH) has a profitability rating of 7 / 10.


What is the valuation of APOLLO MEDICAL HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for APOLLO MEDICAL HOLDINGS INC (AMEH) is 40.82 and the Price/Book (PB) ratio is 3.2.


What is the earnings growth outlook for APOLLO MEDICAL HOLDINGS INC?

The Earnings per Share (EPS) of APOLLO MEDICAL HOLDINGS INC (AMEH) is expected to grow by 15.47% in the next year.